These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Statland JM; Moore D; Wang Y; Walsh M; Mozaffar T; Elman L; Nations SP; Mitsumoto H; Fernandes JA; Saperstein D; Hayat G; Herbelin L; Karam C; Katz J; Wilkins HM; Agbas A; Swerdlow RH; Santella RM; Dimachkie MM; Barohn RJ; Muscle Nerve; 2019 Feb; 59(2):201-207. PubMed ID: 30192007 [TBL] [Abstract][Full Text] [Related]
7. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? Bellingham MC CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142 [TBL] [Abstract][Full Text] [Related]
8. Riluzole for the treatment of amyotrophic lateral sclerosis. Saitoh Y; Takahashi Y Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483 [TBL] [Abstract][Full Text] [Related]
12. Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis. Morren JA; Galvez-Jimenez N Expert Opin Investig Drugs; 2012 Mar; 21(3):297-320. PubMed ID: 22303913 [TBL] [Abstract][Full Text] [Related]
13. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M; J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433 [TBL] [Abstract][Full Text] [Related]
14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
15. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis]. Roch-Torreilles I; Camu W; Hillaire-Buys D Therapie; 2000; 55(2):303-12. PubMed ID: 10967703 [TBL] [Abstract][Full Text] [Related]
16. Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block. Cifra A; Nani F; Nistri A Eur J Neurosci; 2011 Mar; 33(5):899-913. PubMed ID: 21324003 [TBL] [Abstract][Full Text] [Related]
17. [Riluzole as a treatment for amyotrophic lateral sclerosis]. Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030 [TBL] [Abstract][Full Text] [Related]
18. From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies. Mignani S; Majoral JP; Desaphy JF; Lentini G Molecules; 2020 Jul; 25(15):. PubMed ID: 32707914 [TBL] [Abstract][Full Text] [Related]
19. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole. Ceccanti M; Onesti E; Rubino A; Cambieri C; Tartaglia G; Miscioscia A; Frasca V; Inghilleri M Brain Stimul; 2018; 11(4):775-781. PubMed ID: 29459142 [TBL] [Abstract][Full Text] [Related]
20. [Etiological drug therapy for amyotrophic lateral sclerosis]. Cintas P Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]